Key points are not available for this paper at this time.
The US government, backed by the pharmaceutical industry, wants to convince Americans that they're paying more for drugs because they're contributing more than their fair share of the costs of research and development. Not so, argue two researchers who have looked at the evidence.
Light et al. (Thu,) studied this question.